Welcome to our dedicated page for Allegion Plc SEC filings (Ticker: ALLE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allegion plc (NYSE: ALLE) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Allegion is an Ireland-domiciled public limited company whose ordinary shares are listed on the New York Stock Exchange, and it files current reports, financial statements and other documents under U.S. securities laws.
Among the key filings are Form 8‑K current reports, where Allegion discloses material events. Recent 8‑K filings include announcements of quarterly financial results, such as the press release detailing third-quarter 2025 performance, and a filing describing the First Amendment to the company’s amended and restated credit agreement. That amendment increased the aggregate revolving commitments under Allegion’s revolving credit facility, extended its maturity date and outlined the option to request additional capacity, as well as the use of borrowings to repay an existing term loan.
Allegion’s filings also identify its listed securities, including ordinary shares and 3.500% Senior Notes due 2029, both registered under Section 12(b) of the Exchange Act and traded on the New York Stock Exchange. Through quarterly and annual reports (Forms 10‑Q and 10‑K, when available), investors can review segment information for Allegion Americas and Allegion International, along with consolidated financial statements, risk factors and management’s discussion of results.
On Stock Titan, these SEC filings are updated as they appear on EDGAR and are paired with AI-powered summaries that highlight the most important points, such as changes to credit facilities, earnings highlights, capital allocation decisions and other material disclosures. Users can quickly scan complex documents, then drill into the full text of filings for deeper analysis, including details on liquidity, debt, dividends and non‑GAAP financial measures that Allegion uses to describe its underlying business performance.
Allegion plc SVP and CFO Michael J. Wagnes reported routine share dispositions tied to tax withholding. On two dates, a total of 861 Ordinary Shares were withheld by Allegion at $162.92 per share to cover tax obligations from vesting restricted stock units, leaving him holding over 31,000 shares directly.
Allegion plc senior executive receives equity awards. SVP - Allegion Americas David S. Ilardi reported acquiring 6,414 stock options and 1,691 ordinary shares as equity grants.
The ordinary share award consists of restricted stock units that vest in three equal annual installments on February 19, 2027, 2028, and 2029. The stock option grant vests on the same schedule, aligning his compensation with Allegion’s longer-term performance.
Allegion plc senior vice president Tracy L. Kemp received equity awards on February 19, 2026. Kemp was granted stock options for 3,499 shares at an exercise price of $0.00 per share and 923 restricted stock units. Both the options and restricted stock units vest in three equal annual installments on February 19, 2027, February 19, 2028 and February 19, 2029. Following these awards, Kemp directly holds 11,645 ordinary shares and 3,499 stock options.
Allegion plc senior vice president Timothy P. Eckersley reported equity awards under the company’s compensation program. He received a grant of stock options for 6,414 shares at an exercise price of $0.0000 per share and a grant of 1,691 ordinary shares, both acquired as awards rather than open-market purchases.
The 1,691-share grant represents restricted stock units that vest in equal annual installments on February 19, 2027, February 19, 2028, and February 19, 2029. The stock options vest on the same three annual dates in equal installments. After the share grant, Eckersley directly owns 37,004 ordinary shares.
Allegion plc senior executive Vincent Wenos reported equity awards rather than open-market trades. On February 19, 2026, he received stock options for 3,790 shares at an exercise price of $0.00 per share and a grant of 999 ordinary shares.
The 999 ordinary shares are restricted stock units that vest in equal annual installments on February 19, 2027, February 19, 2028, and February 19, 2029. The 3,790 stock options vest on the same schedule. After these awards, his direct holdings totaled 13,383 ordinary shares.
Wagnes Michael J. reported acquisition or exercise transactions in this Form 4 filing.
Allegion plc reported that its SVP and CFO, Michael J. Wagnes, received new equity awards on February 19, 2026. He was granted stock options for 9,329 shares and 2,460 ordinary shares in the form of restricted stock units as part of his compensation.
The restricted stock units vest in three equal annual installments on February 19, 2027, 2028, and 2029. The stock option grant vests on the same schedule. After these awards, Wagnes directly holds 32,642 ordinary shares and 9,329 stock options.
Martens Robert C. reported acquisition or exercise transactions in this Form 4 filing.
Allegion plc senior vice president Robert C. Martens received new equity awards. He was granted 1,076 ordinary shares and stock options for 4,082 shares at no cost. The restricted stock units and options vest in equal annual installments on February 19, 2027, 2028 and 2029, encouraging longer-term retention.
Allegion plc executive Nickolas A. Musial, VP, Controller & CAO, reported equity awards received on February 19, 2026. He was granted stock options for 1,750 shares at an exercise price of $0.0000 per share, bringing his directly held options to 1,750.
On the same date, he also received 923 ordinary shares as a grant, increasing his direct holdings of ordinary shares to 7,067. The 923-share award consists of restricted stock units that vest in equal annual installments on February 19, 2027, February 19, 2028 and February 19, 2029; the stock options follow the same three-year vesting schedule.
Allegion plc reported that SVP and General Counsel Joseph Blasko received new equity awards. He was granted a stock option for 5,248 shares at an exercise price of $0.00 per share and an award linked to 1,384 ordinary shares, both classified as acquisitions.
The footnotes state that the restricted stock units vest in equal annual installments on February 19, 2027, February 19, 2028, and February 19, 2029, and the stock option vests on the same schedule. No open-market purchases or sales were reported in this filing.
Allegion plc senior vice president and Chief HR Officer Jennifer L. Hawes reported equity awards. She acquired stock options for 4,082 shares at a grant price of $0 and 1,076 ordinary shares. Both the options and restricted stock units vest in three equal annual installments on February 19, 2027, 2028 and 2029.